Reuters Taking a sample or
biopsy from just one part of a tumor might not give a full picture of
its genetic diversity and may explain why doctors, despite using
genetically targeted drugs, are often unable to save patients whose
cancer has spread, scientists said. A study by British researchers
found there are more genetic differences than similarities between
biopsies taken from separate areas of the same tumor, and yet further
gene differences in samples taken from secondary tumors. That
might help explain why, despite recent development of a wave of highly
targeted drugs designed to tackle cancers of specific genetic types, the
prognosis remains poor for many patients with so-called solid-tumor
disease like breast, lung, or kidney cancer that has spread to others
parts of the body... Read More